Retargeting serum immunoglobulin with bispecific diabodies

被引:67
作者
Holliger, P
Wing, M
Pound, JD
Bohlen, H
Winter, G
机构
[1] UNIV CAMBRIDGE,ADDENBROOKES HOSP,NEUROL UNIT,CAMBRIDGE CB2 2QQ,ENGLAND
[2] UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[3] UNIV COLOGNE,INNERE MED KLIN 1,D-50931 COLOGNE,GERMANY
[4] MRC,MOL BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND
关键词
antibody engineering; diabody; immunotherapy;
D O I
10.1038/nbt0797-632
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Monospecific antibody fragments produced in bacteria lack the Fc portion of antibodies, and are therefore unable to recruit natural effector functions. We describe the use of a bispecific antibody fragment (diabody) to recruit the whole spectrum of antibody effector functions by retargeting serum immunoglobulin (Ig). One arm of the diabody was directed against the target antigen, and the other against the serum Ig. The bispecific diabodies were able to recruit complement, induce mononuclear phagocyte respiratory burst and phagocytosis, and promote synergistic cytotoxicity towards colon carcinoma cells in conjunction with CD8(+) T-cells, Further, by virtue of binding to serum Ig their half-life (beta-phase) was increased fivefold compared to a control diabody of the same molecular weight. Such bispecific diabodies may provide an attractive alternative to monoclonal antibodies for serotherapy.
引用
收藏
页码:632 / 636
页数:5
相关论文
共 34 条
[1]   DIFFERENTIATION OF CYTOTOXICITY USING TARGET-CELLS LABELED WITH EUROPIUM AND SAMARIUM BY ELECTROPORATION [J].
BOHLEN, H ;
MANZKE, O ;
ENGERT, A ;
HERTEL, M ;
HIPPLERALTENBURG, R ;
DIEHL, V ;
TESCH, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 173 (01) :55-62
[2]   THE IMMUNOGENICITY OF CHIMERIC ANTIBODIES [J].
BRUGGEMANN, M ;
WINTER, G ;
WALDMANN, H ;
NEUBERGER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2153-2157
[3]   PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES [J].
CHESTER, KA ;
BEGENT, RHJ ;
ROBSON, L ;
KEEP, P ;
PEDLEY, RB ;
BODEN, JA ;
BOXER, G ;
GREEN, A ;
WINTER, G ;
COCHET, O ;
HAWKINS, RE .
LANCET, 1994, 343 (8895) :455-456
[4]  
CLARKSON T, 1991, NATURE, V352, P624
[5]  
CUMBER AJ, 1992, J IMMUNOL, V149, P120
[6]   ISOLATION OF HIGH-AFFINITY HUMAN-ANTIBODIES DIRECTLY FROM LARGE SYNTHETIC REPERTOIRES [J].
GRIFFITHS, AD ;
WILLIAMS, SC ;
HARTLEY, O ;
TOMLINSON, IM ;
WATERHOUSE, P ;
CROSBY, WL ;
KONTERMANN, RE ;
JONES, PT ;
LOW, NM ;
ALLISON, TJ ;
PROSPERO, TD ;
HOOGENBOOM, HR ;
NISSIM, A ;
COX, JPL ;
HARRISON, JL ;
ZACCOLO, M ;
GHERARDI, E ;
WINTER, G .
EMBO JOURNAL, 1994, 13 (14) :3245-3260
[7]   Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody [J].
Holliger, P ;
Brissinck, J ;
Williams, RL ;
Thielemans, K ;
Winter, G .
PROTEIN ENGINEERING, 1996, 9 (03) :299-305
[8]   DIABODIES - SMALL BIVALENT AND BISPECIFIC ANTIBODY FRAGMENTS [J].
HOLLIGER, P ;
PROSPERO, T ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6444-6448
[9]  
Holliger Philipp, 1993, Current Opinion in Biotechnology, V4, P446, DOI 10.1016/0958-1669(93)90010-T
[10]   MULTISUBUNIT PROTEINS ON THE SURFACE OF FILAMENTOUS PHAGE - METHODOLOGIES FOR DISPLAYING ANTIBODY (FAB) HEAVY AND LIGHT-CHAINS [J].
HOOGENBOOM, HR ;
GRIFFITHS, AD ;
JOHNSON, KS ;
CHISWELL, DJ ;
HUDSON, P ;
WINTER, G .
NUCLEIC ACIDS RESEARCH, 1991, 19 (15) :4133-4137